NORMAN LEARNER; WILLIAM R. MINNICH
The introduction of streptomycin has provided a new antibiotic effective against many Gram negative organisms unaffected by penicillin. The Friedländer bacillus (Klebsiella pneumoniae) has been shown to be susceptible to streptomycin in vitro,1 but the effect of this agent on acute Friedländer pneumonia is not known.2 Recently, the opportunity arose for just such a therapeutic trial. The patient responded so rapidly to streptomycin that a report was felt justified, especially since this type of pneumonia is so refractory to other drugs.
The patient, a 36 year old white infantry soldier, sustained a penetrating shell fragment wound of the
LEARNER N, MINNICH WR. FRIEDLÄNDER PNEUMONIA TREATED WITH STREPTOMYCIN; REPORT OF A CASE WITH PROMPT RECOVERY1. Ann Intern Med. ;25:516–520. doi: 10.7326/0003-4819-25-3-516
Download citation file:
Published: Ann Intern Med. 1946;25(3):516-520.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use